Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Pancreatic disease Stories

Managing Diabetes Via Pancreas Removal
2012-08-30 06:15:13

Connie K. Ho for redOrbit.com — Your Universe Online Fatigue. Hunger. Weight loss. These are just a few of the symptoms related to diabetes. With the diagnosis of the disease, it can sometimes be difficult for patients to manage. However, researchers from the Mayo Clinic recently discovered that, after removal of the entire pancreas, patients can better control their diabetes. Before the procedure, these patients were identified as having cancer or precancerous cysts in the...

2012-07-06 23:00:34

Minimally invasive procedure removed precancerous cyst, offers a shorter hospital stay and faster recovery. Philadelphia, PA (PRWEB) July 07, 2012 Eugene Allen, a retired police officer and teacher from Sicklerville, N.J., had a decision to make in February, after an MRI revealed a precancerous cyst in his pancreas. It had to be removed, but the question was how? The active 60-year-old wanted to get back to the long walks with his dog and taking care of his in ground pool. He could go the...

2012-05-22 08:34:02

A routine endoscopy can detect cancer in the pancreas in the nearby adjacent small intestine due to cancer's 'field effect' By simply shining a tiny light within the small intestine, close to that organ's junction with the pancreas, physicians at Mayo Clinic's campus in Florida have been able to detect pancreatic cancer 100 percent of the time in a small study. The light, attached to a probe, measures changes in cells and blood vessels in the small intestine produced by a growing cancer in...

2012-01-31 11:00:00

Breakthrough therapy targets defective protein SILVER SPRING, Md., Jan. 31, 2012 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Kalydeco (ivacaftor) for the treatment of a rare form of cystic fibrosis (CF) in patients ages 6 years and older who have the specific G551D mutation in the Cystic Fibrosis Transmembrane Regulator (CFTR) gene. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) CF is a serious genetic disorder affecting the lungs...

2011-12-12 12:11:51

A rare genetic disorder has given researchers at the University of Exeter a surprising insight into how the pancreas develops. The finding provides a clue to how it may be possible to 'program' stem cells — master cells in the body that can develop into specialized cells — to become pancreatic cells. Pancreatic agenesis is a rare condition in which the body is unable to produce a pancreas. The pancreas plays an essential role in regulating levels of sugar (glucose) in the...

2011-11-11 06:51:45

(Ivanhoe Newswire) — Hope for better lungs! According to a recent study, the oral medication ivacaftor provides major, sustained improvement in lung function, growth and other signs and symptoms for cystic fibrosis patients. The study marks the first time a drug has been shown to work on the disease process rather than on the symptoms. Cystic fibrosis, which has no cure, is the most common lethal genetic disease in Caucasians. "Ivacaftor represents a significant advancement in the...

2011-11-04 10:17:16

Case Western Reserve University School of Medicine, UH Rainbow Babies and Children's Hospital researcher co-authors major clinical trial Results of the pivotal Phase 3 clinical trial published in the Nov. 3, 2011 (embargoed 5 pm ET, Nov. 2, '11) New England Journal of Medicine, find that the oral medication ivacaftor (VX-770) provides major, sustained improvement in lung function, growth and other signs and symptoms for cystic fibrosis (CF) patients. The multi-site study marks the first...

2011-10-13 10:05:54

Particular types of mouth bacteria, some of which are found in gum disease, are associated with the development of pancreatic cancer, indicates a small study published online in the journal Gut. The finding opens up the possibility of curbing the progress of one of the most difficult cancers to treat, by altering the balance of bacteria, say the authors. Pancreatic cancer usually spreads very quickly, and only around one in 20 patients is still alive five years after diagnosis. The...

2011-09-01 16:42:25

Researchers have identified an unconventional path that may correct the defect underlying cystic fibrosis, according to a report in the September 2nd issue of the journal Cell, a Cell Press publication. This new treatment dramatically extends the lives of mice carrying the disease-associated mutation. Cystic Fibrosis is caused by a mutation in a gene responsible for the transport of ions across cell membranes. This gene encodes a protein channel, called the cystic fibrosis transmembrane...

2011-06-14 08:30:00

ABBOTT PARK, Ill., June 14, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON(R) (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF). The CREON 3,000 units of lipase capsule provides the lowest dosage strength in the class approved by the FDA. This new option will enable more precise dosing titration in accordance with the...